NK cells expressing a progesterone receptor are susceptible to progesterone-induced apoptosis

被引:121
作者
Arruvito, Lourdes [1 ,2 ]
Giulianelli, Sebastian [3 ]
Flores, Ana C. [1 ,2 ]
Paladino, Natalia [1 ,2 ]
Barboza, Marcos [1 ]
Lanari, Claudia [3 ]
Fainboim, Leonardo [1 ,2 ]
机构
[1] Univ Buenos Aires, Sch Med, Immunogenet Lab, Jose de San Martin Clin Hosp, RA-1120 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Sch Med, Dept Microbiol Immunol & Parasitol, RA-1120 Buenos Aires, DF, Argentina
[3] Natl Council Sci & Technol Res, Lab Hormonal Carcinogenesis, Inst Biol & Med Expt, Buenos Aires, DF, Argentina
关键词
D O I
10.4049/jimmunol.180.8.5746
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It has been proposed that progesterone (P4) induces the suppression of immune responses, particularly during pregnancy. However, knowledge about the mechanisms involved has remained largely elusive. We demonstrate herein that peripheral blood NK (PBNK) cells express both classical progesterone receptor (PR) isoforms and are specifically affected by the actions of P4 through two apparently independent mechanisms. Progesterone induces caspase-dependent PBNK cell death, which is reversed by two different anti-progestins, ZK 98.299 and RU 486, supporting the involvement of classical PR isoforms. It was suggested that CD56(bright)CD16(-) killer Ig-like receptor (KIR)(-) NK cells might represent precursor cells, which, upon activation, acquire the features of a more mature NK subset expressing KIR receptors. The present study demonstrates that PR expression seems to be restricted to more mature KIR+ PBNK cells. The expression of PR had a functional counterpart in the suppressive effect of P4 on IL-12-induced IFN-gamma secretion. This cytokine suppression was mainly observed in KIR+ PBNK cells, without affecting the high secretion of IFN-gamma by CD56(bright) PBNK cells. The lack of PR expression on CD56(bright)KIR(-) PBNK cells provides an additional phenotypic marker to test the idea that they might represent the PBNK precursors selectively recruited into the endometrium where they differentiate to become the uterine NK cells. Additionally, these findings may be relevant to NK cell function in viral immunity, human reproduction, and tumor immunity.
引用
收藏
页码:5746 / 5753
页数:8
相关论文
共 44 条
[1]   Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene [J].
Aldaz, CM ;
Liao, QY ;
LaBate, M ;
Johnston, DA .
CARCINOGENESIS, 1996, 17 (09) :2069-2072
[2]   Expansion of CD4+CD25+ and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle:: Implications for human reproduction [J].
Arruvito, Lourdes ;
Sanz, Marianela ;
Banham, Alison H. ;
Fainboim, Leonardo .
JOURNAL OF IMMUNOLOGY, 2007, 178 (04) :2572-2578
[3]   TRANSCRIPTIONAL CONTROL BY NUCLEAR RECEPTORS [J].
BEATO, M .
FASEB JOURNAL, 1991, 5 (07) :2044-2051
[4]   A novel developmental and immunodeficiency syndrome associated with intrauterine growth retardation and a lack of natural killer cells [J].
Bernard, F ;
Picard, C ;
Cormier-Daire, V ;
Eidenschenk, C ;
Pinto, G ;
Bustamante, JC ;
Jouanguy, E ;
Teillac-Hamel, D ;
Colomb, V ;
Funck-Brentano, I ;
Pascal, V ;
Vivier, E ;
Fischer, A ;
Le Deist, F ;
Casanova, JL .
PEDIATRICS, 2004, 113 (01) :136-141
[5]   TYPE-II ANTAGONISTS IMPAIR THE DNA-BINDING OF STEROID-HORMONE RECEPTORS WITHOUT AFFECTING DIMERIZATION [J].
BOCQUEL, MT ;
JI, JW ;
YLIKOMI, T ;
BENHAMOU, B ;
VERGEZAC, A ;
CHAMBON, P ;
GRONEMEYER, H .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1993, 45 (04) :205-215
[6]   Vital involvement of a natural killer cell activation receptor in resistance to viral infection [J].
Brown, MG ;
Dokun, AO ;
Heusel, JW ;
Smith, HRC ;
Beckman, DL ;
Blattenberger, EA ;
Dubbelde, CE ;
Stone, LR ;
Scalzo, AA ;
Yokoyama, WM .
SCIENCE, 2001, 292 (5518) :934-937
[7]  
Cadepond F, 1997, ANNU REV MED, V48, P129
[8]  
Cato A.C., 2002, SCI STKE, V2002, pre9, DOI [DOI 10.1126/STKE.2002.138.RE9, 10.1126/stke.2002.138.re9]
[9]   A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk [J].
De Vivo, I ;
Huggins, GS ;
Hankinson, SE ;
Lescault, PJ ;
Boezen, M ;
Colditz, GA ;
Hunter, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) :12263-12268
[10]   A nongenomic mechanism for progesterone-mediated immunosuppression:: Inhibition of K+ channels, Ca2+ signaling, and gene expression in T lymphocytes [J].
Ehring, GR ;
Kerschbaum, HH ;
Eder, C ;
Neben, AL ;
Fanger, CM ;
Khoury, RM ;
Negulescu, P ;
Cahalan, MD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (09) :1593-1602